Trial
NCT00003491
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Stage IV Lung Cancer
Intervention
Antineoplaston therapy (Atengenal + Astugenal)
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-29